Propel Bio Management »

Kalaris Therapeutics shares owned by Propel Bio Management

Quarter-by-quarter ownership of Kalaris Therapeutics (KLRS) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Kalaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kalaris Therapeutics held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalaris Therapeutics by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $355k 42k 8.44